vTv Therapeutics Inc.
VTVTNext catalyst
Cadisegliatin
Diabetes Mellitus, Type 1
Get an email about VTVT's next catalysts
Track vTv Therapeutics (VTVT) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 1 past
Cadisegliatin Phase 3 Est. Readout (CATT1)
Estimated primary completion for Cadisegliatin trial (NCT06334133) in Diabetes Mellitus, Type 1. Topline data typically follows completion by weeks to months.
SourceMarket Overview
Stock performance and key metrics
Cadisegliatin
Diabetes Mellitus, Type 1
GK1-399 (formerly TTP399)
Type 2 Diabetes Mellitus
TTP054
Type 2 Diabetes Mellitus
TTP399
Diabetes Mellitus, Type 1
TTP273
Type 2 Diabetes Mellitus
TTP435
Obesity
TTP889
Venous Thromboembolism
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Cadisegliatin | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
GK1-399 (formerly TTP399) | Phase 2 | Type 2 Diabetes Mellitus | - | - |
TTP054 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
TTP399 | Phase 2 | Diabetes Mellitus, Type 1 | - | - |
TTP273 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
TTP435 | Phase 2 | Obesity | - | - |
TTP889 | Phase 2 | Venous Thromboembolism | - | - |
Frequently asked questions
What is in vTv Therapeutics Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in vTv Therapeutics Inc.'s (VTVT) pipeline across Phase 3, Phase 2. Its lead program is Cadisegliatin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is vTv Therapeutics Inc.'s next FDA catalyst?→
vTv Therapeutics Inc.'s (VTVT) next tracked catalyst is a Phase 3 readout expected April 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VTVT biotech catalysts?→
Add VTVT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow vTv Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.